LGVN News and Press, Longeveron Inc. From 01/31/24

Humans need a healthy amount of muscle mass to stay spry and healthy, especially as they age. High muscle mass helps to increase metabolism and makes it easier to maintain a healthy weight level, says Washington, D.C., dietician Caroline Thomason, RD, CDCES. She explains that muscles are among ...

Longeveron (NASDAQ: LGVN) , a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, has received notice from the United States Patent and Trademark Office (“USPTO”) of patent allowance for Medicinal Signaling Ce...

MIAMI, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions , today announces it received a notice of...

Researchers have determined that there are different types of Alzheimer’s after they studied proteins found in cerebrospinal fluid. Alzheimer’s is a common form of dementia. This progressive illness often starts with memory loss and causes patients to lose their ability to speak...

It is estimated that more than six million Americans suffer from Alzheimer’s, with data from the Alzheimer’s Association showing that every 67 seconds, another individual develops the illness. This progressive illness affects parts of the brain that control memory, thought and lang...

2023-12-21 12:18:35 ET Gainers: Infrared Cameras Holdings ( MSAI ) +195% . Mullen Automotive ( MULN ) +112% . Baijiayun Group Ltd ( RTC ) +33% . HeartBeam ( BEAT ) +31% . Triumph Group ( TGI ) +32% . TC BioPharm ( TCBP ) ...

MIAMI, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (...

2023-12-21 08:31:47 ET More on Longeveron Longeveron Inc. (LGVN) Q3 2023 Earnings Call Transcript Longeveron Inc. 2023 Q3 - Results - Earnings Call Presentation Longeveron reports positive results from Alzheimer's treatment trial Longeveron GAAP EPS of -$0.28...

2023-12-21 08:16:36 ET Losers: Polished.com ( POL ) -36% . Dune Acquisition Corporation ( DUNE ) -17% . Panbela Therapeutics ( PBLA ) -10% . Applied UV ( AUVI ) -9% . Tantech Holdings Ltd ( TANH ) -9% . Longeveron ( LGVN ...

MIAMI, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (...